Cargando…
Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and commun...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892511/ https://www.ncbi.nlm.nih.gov/pubmed/32885314 http://dx.doi.org/10.1007/s00520-020-05692-7 |
_version_ | 1783652861108813824 |
---|---|
author | Pichler, Theresia Rohrmoser, Amy Letsch, Anne Westphalen, C. Benedikt Keilholz, Ulrich Heinemann, Volker Lamping, Mario Jost, Philipp J. Riedmann, Kristina Herschbach, Peter Goerling, Ute |
author_facet | Pichler, Theresia Rohrmoser, Amy Letsch, Anne Westphalen, C. Benedikt Keilholz, Ulrich Heinemann, Volker Lamping, Mario Jost, Philipp J. Riedmann, Kristina Herschbach, Peter Goerling, Ute |
author_sort | Pichler, Theresia |
collection | PubMed |
description | PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and communication. To meet these challenges, healthcare professionals need to gain deeper insight into patients’ subjective experiences. Therefore, this qualitative study examined information aspects of MD programs in cancer patients. METHODS: In two German Comprehensive Cancer Centers, 30 cancer patients undergoing MD participated in semi-structured interviews on information transfer and information needs regarding MD. Additionally, patients provided sociodemographic and medical data and indicated their subjective level of information (visual analogue scale, VAS, 0–10). RESULTS: On average patients had high levels of information (mean = 7, median = 8); nevertheless 20% (n = 6) showed an information level below 5 points. Qualitative analysis revealed that patients show limited understanding of the complex background of MD and have uncertainties regarding their personal benefit. Further, patients described unmet information needs. Existential threat in awaiting the results was experienced as burdensome. To withstand the strains of their situation, patients emphasized the importance of trusting their physician. CONCLUSION: The challenges in PCM consist in providing unambiguous information, especially concerning treatment benefit, and providing guidance and support. Therefore, psycho-oncology needs to develop guidelines for adequate patient communication in order to help healthcare providers and cancer patients to handle these challenges in the developing field of PCM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05692-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7892511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78925112021-03-03 Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? Pichler, Theresia Rohrmoser, Amy Letsch, Anne Westphalen, C. Benedikt Keilholz, Ulrich Heinemann, Volker Lamping, Mario Jost, Philipp J. Riedmann, Kristina Herschbach, Peter Goerling, Ute Support Care Cancer Original Article PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and communication. To meet these challenges, healthcare professionals need to gain deeper insight into patients’ subjective experiences. Therefore, this qualitative study examined information aspects of MD programs in cancer patients. METHODS: In two German Comprehensive Cancer Centers, 30 cancer patients undergoing MD participated in semi-structured interviews on information transfer and information needs regarding MD. Additionally, patients provided sociodemographic and medical data and indicated their subjective level of information (visual analogue scale, VAS, 0–10). RESULTS: On average patients had high levels of information (mean = 7, median = 8); nevertheless 20% (n = 6) showed an information level below 5 points. Qualitative analysis revealed that patients show limited understanding of the complex background of MD and have uncertainties regarding their personal benefit. Further, patients described unmet information needs. Existential threat in awaiting the results was experienced as burdensome. To withstand the strains of their situation, patients emphasized the importance of trusting their physician. CONCLUSION: The challenges in PCM consist in providing unambiguous information, especially concerning treatment benefit, and providing guidance and support. Therefore, psycho-oncology needs to develop guidelines for adequate patient communication in order to help healthcare providers and cancer patients to handle these challenges in the developing field of PCM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05692-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-09-03 2021 /pmc/articles/PMC7892511/ /pubmed/32885314 http://dx.doi.org/10.1007/s00520-020-05692-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Pichler, Theresia Rohrmoser, Amy Letsch, Anne Westphalen, C. Benedikt Keilholz, Ulrich Heinemann, Volker Lamping, Mario Jost, Philipp J. Riedmann, Kristina Herschbach, Peter Goerling, Ute Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title | Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title_full | Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title_fullStr | Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title_full_unstemmed | Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title_short | Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
title_sort | information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892511/ https://www.ncbi.nlm.nih.gov/pubmed/32885314 http://dx.doi.org/10.1007/s00520-020-05692-7 |
work_keys_str_mv | AT pichlertheresia informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT rohrmoseramy informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT letschanne informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT westphalencbenedikt informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT keilholzulrich informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT heinemannvolker informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT lampingmario informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT jostphilippj informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT riedmannkristina informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT herschbachpeter informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine AT goerlingute informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine |